PortfoliosLab logoPortfoliosLab logo
DFTX vs. ATAI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

DFTX vs. ATAI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Definium Therapeutics, Inc (DFTX) and Atai Life Sciences N.V. (ATAI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DFTX achieves a 225.02% return, which is significantly higher than ATAI's 75.55% return.


DFTX

1D
-2.18%
1M
-1.52%
6M
157.82%
YTD
225.02%
1Y
415.64%
3Y*
107.23%
5Y*
10Y*
ALL TIME*
42.51%

ATAI

1D
0.00%
1M
38.34%
6M
90.96%
YTD
75.55%
1Y
72.18%
3Y*
51.86%
5Y*
-14.26%
10Y*
ALL TIME*
-18.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$95.05M$137.83M$67.37M
$64.44M$84.24M$99.34M

DFTX vs. ATAI - Yearly Performance Comparison


2026 (YTD)2025202420232022
DFTX
Definium Therapeutics, Inc
225.02%92.39%90.16%66.36%-78.74%
ATAI
Atai Life Sciences N.V.
75.55%207.52%-5.67%-46.99%-38.28%

Correlation

The correlation between DFTX and ATAI is 0.52, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.52

Correlation (3Y)
Balances recent behavior with more history.

0.49

Correlation (All Time)
Calculated using the full available price history since Jul 11, 2022

0.44

The correlation between DFTX and ATAI has been stable across timeframes, ranging from 0.44 to 0.52 - a consistent structural relationship.

Fundamentals

Market Cap

DFTX:

$4.75B

ATAI:

$2.66B

EPS

DFTX:

-$2.51

ATAI:

-$2.50

PB Ratio

DFTX:

16.98

ATAI:

12.92

Total Revenue (TTM)

DFTX:

$0.00

ATAI:

$3.49M

Gross Profit (TTM)

DFTX:

$0.00

ATAI:

$3.49M

EBITDA (TTM)

DFTX:

-$206.36M

ATAI:

-$663.38M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DFTX vs. ATAI — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

DFTX
DFTX Risk / Return Rank: 9999
Overall Rank
DFTX Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
DFTX Sortino Ratio Rank: 9999
Sortino Ratio Rank
DFTX Omega Ratio Rank: 9797
Omega Ratio Rank
DFTX Calmar Ratio Rank: 9999
Calmar Ratio Rank
DFTX Martin Ratio Rank: 9999
Martin Ratio Rank

ATAI
ATAI Risk / Return Rank: 7474
Overall Rank
ATAI Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
ATAI Sortino Ratio Rank: 7979
Sortino Ratio Rank
ATAI Omega Ratio Rank: 7676
Omega Ratio Rank
ATAI Calmar Ratio Rank: 7474
Calmar Ratio Rank
ATAI Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

DFTX vs. ATAI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Definium Therapeutics, Inc (DFTX) and Atai Life Sciences N.V. (ATAI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


DFTXATAIDifference
Sharpe ratioReturn per unit of total volatility

+3.86

Sortino ratioReturn per unit of downside risk

+3.16

Omega ratioGain probability vs. loss probability

1.60

1.23

+0.37

Calmar ratioReturn relative to maximum drawdown

15.40

1.57

+13.83

Martin ratioReturn relative to average drawdown

47.19

2.43

+44.76

DFTX vs. ATAI - Sharpe Ratio Comparison

The current DFTX Sharpe Ratio is 4.79, which is higher than the ATAI Sharpe Ratio of 0.94. The chart below compares the historical Sharpe Ratios of DFTX and ATAI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

DFTX vs. ATAI - Drawdown Comparison

The maximum DFTX drawdown since its inception was -86.01%, smaller than the maximum ATAI drawdown of -95.05%. Use the drawdown chart below to compare losses from any high point for DFTX and ATAI.


Loading charts...

Drawdown Indicators


DFTXATAIDifference

Max Drawdown

Largest peak-to-trough decline

-86.01%

-95.05%

+9.04%

Max Drawdown (1Y)

Largest decline over 1 year

-24.79%

-48.06%

+23.27%

Max Drawdown (3Y)

Largest decline over 3 years

-58.38%

-59.23%

+0.85%

Max Drawdown (5Y)

Largest decline over 5 years

-94.17%

Current Drawdown

Current decline from peak

-10.18%

-65.81%

+55.63%

Average Drawdown

Average peak-to-trough decline

-49.74%

-80.58%

+30.84%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.09%

30.99%

-22.90%

Volatility

DFTX vs. ATAI - Volatility Comparison

The current volatility for Definium Therapeutics, Inc (DFTX) is 16.10%, while Atai Life Sciences N.V. (ATAI) has a volatility of 33.68%. This indicates that DFTX experiences smaller price fluctuations and is considered to be less risky than ATAI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DFTXATAIDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.10%

33.68%

-17.58%

Volatility (6M)

Calculated over the trailing 6-month period

56.99%

61.09%

-4.10%

Volatility (1Y)

Calculated over the trailing 1-year period

79.66%

82.57%

-2.91%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

87.09%

85.28%

+1.81%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

87.09%

84.88%

+2.21%

Dividends

DFTX vs. ATAI - Dividend Comparison

Neither DFTX nor ATAI has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

DFTX vs. ATAI - Financials Comparison

This section allows you to compare key financial metrics between Definium Therapeutics, Inc and Atai Life Sciences N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


DFTX and ATAI have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ATAI has higher volatility (33.68%) compared to DFTX (16.10%). In terms of maximum drawdown, DFTX dropped -86.01% vs ATAI's -95.05%.

DFTX currently has the higher Sharpe Ratio (4.79 vs 0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DFTX and ATAI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer